Thursday, Jul 02, 2020 | Last Update : 12:55 PM IST

100th Day Of Lockdown

Maharashtra180298931548053 Tamil Nadu94049529261264 Delhi89802599922803 Gujarat33318240381869 Uttar Pradesh2405616629718 West Bengal1917012528683 Rajasthan1831214574421 Telangana173578082267 Karnataka165148065253 Andhra Pradesh152526988193 Haryana1494110499240 Madhya Pradesh1386110655581 Bihar10204781173 Assam8956583212 Jammu and Kashmir76954856105 Odisha7316535333 Punjab56683989149 Kerala4594243626 Uttarakhand2791190937 Chhatisgarh2339193713 Jharkhand2339160512 Tripura140110931 Manipur12605790 Goa11984783 Himachal Pradesh9796179 Puducherry73930112 Nagaland5351820 Chandigarh4463676 Arunachal Pradesh182601 Mizoram1601230 Sikkim88490 Meghalaya50421
  World   Americas  26 May 2020  WHO suspends testing hydroxychloroquine on virus patients

WHO suspends testing hydroxychloroquine on virus patients

REUTERS
Published : May 26, 2020, 12:16 pm IST
Updated : May 26, 2020, 12:16 pm IST

Hydroxycholoroquine has been touted by Donald Trump and many others as a possible treatment for COVID-19

A chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP)
 A chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP)

Geneva: The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.

Hydroxychloroquine has been touted by Donald Trump and many others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection.

 

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” Tedros told an online briefing.

He said the other arms of the trial - a major international initiative to hold clinical tests of potential treatments for the virus - were continuing.

The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.

Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”.

Tags: hydroxychloroquine, coronavirus, covid-19, trump, world health organization, malaria drug, india